#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic cutaneous lupus erythematosus Anal squamous cell carcinoma Biliary cancer metastatic HER2 mutant non-small cell lung cancer Prophylaxis against transplant rejection Cystic fibrosis respiratory infection suppression Cortical dysplasia Atopic keratoconjunctivitis Mucous membrane pemphigoid Synovial sarcoma metastatic Alagille syndrome Guillain-Barre syndrome Obliterative bronchiolitis Infective uveitis Waldenstrom's macroglobulinaemia recurrent More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Trials in Disease Richter’s syndrome – Treatment Hepatic angiosarcoma – Basic Information Proteus syndrome Fabry’s disease – Diagnostics Haemophagocytic lymphohistiocytosis – Diagnostics Primary hyperoxaluria – Life with Disease Chondrosarcoma – Treatment Bronchiolitis obliterans syndrome – Basic Information Atypical haemolytic uraemic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbp030.2 Mk-1088 Dactylis Glomerata FERUMOXTRAN-10 Lutetium (177Lu) Oxodotreotide Vib1116 Olive Oil, Refined Alkaline Phosphatase, Bovine Bosentan Lapatinib GSKVX000000039711 Enlicitide Chloride Hydralazine Hydrochloride Sodium Laurilsulfate Mocravimod Varegacestat LTG-001 Milrinone Acetylsalicylic Acid Blu-263 Phosphate More therapies…

    Learn about Your Condition

    Metastatic gastric cancer Psoriatic arthropathy Haemophilia Migraine without aura Follicular thyroid cancer Elderly Periodontitis Sarcoidosis Pyoderma gangrenosum Orthostatic hypotension Procedural hypotension Circulatory collapse Polycystic ovarian syndrome Hepatic angiosarcoma Mucopolysaccharidosis II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lichen planus

  • A study of upadacitinib in adults with erosive mucosal lichen planus and lichen planopilaris.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Lichen planus
    Investigated Drugs:
    • Upadacitinib
    France

  • Study on the Effectiveness of Deucravacitinib for Patients with Lichen Planus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lichen planus
    • Oral lichen planus
    Investigated Drugs:
    • Deucravacitinib
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!